Executive record

Eric Easom

President, Chief Executive Officer and Board Chair at AN2 Therapeutics, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:eric-easomVersion: public-0As of: 2026-09-28

Not yet claimed8 published Claims3 sources
  • Director

Key Claims

Board service

Boards

Claims

Executive career

  1. 2026 to end not publishedExecutive title: President, Chief Executive Officer and Board Chair · Organization not publishedANTX DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ANTX DEF 14A executive officers

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at AN2 Therapeutics, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: President, Chief Executive Officer and Board Chair · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec def 14a · Source published: Apr 22, 2026 · Retrieved: Sep 5, 2026

    Supports 2 claims
    • Professional Role: President, Chief Executive Officer and Board Chair at AN2 Therapeutics, Inc. · Claim reviewed: Sep 5, 2026
    • Professional Role: President, Chief Executive Officer and Board Chair at AN2 Therapeutics, Inc. · Claim reviewed: Sep 5, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of AN2 Therapeutics, Inc. · Claim reviewed: Sep 5, 2026